TOPIC
To systematically evaluate the clinical utility of multimodal imaging (MMI) for the diagnosis, activity assessment, longitudinal monitoring, and detection of complications in the five most prevalent infectious posterior uveitides.
DESIGN
Systematic review and evidence-based quality appraisal.
PARTICIPANTS
Ori...
Uday Pratap Singh Parmar, R. La Distia Nora, I. Leal et al.· Ophthalmology Retina· 0 citations
X-linked juvenile retinoschisis (XLRS) is a hereditary retinal dystrophy resulting from mutations in the retinoschisin (RS1) gene, which lead to progressive structural abnormalities in the retina and consequent visual impairment. Despite this, the molecular mechanisms through which RS1 mutations induce cell type-specif...
Han-Ping Cheng, Lo-Jei Ching, Chia-Hao Wang et al.· Experimental Eye Research· 0 citations
Achieving complete polypoidal lesion regression is a critical clinical endpoint for ensuring long-term disease stability and reducing the risk of catastrophic recurrence and should nonetheless be regarded as one of several important endpoints - alongside visual acuity, exudative control, safety, and treatment accessibi...
Jun-Wei Chen, De-Kuang Hwang, Yi-Ting Hsieh et al.· Seminars in Ophthalmology· 0 citations
PURPOSE
To evaluate whether pars plana vitrectomy (PPV) performed within 72 hours of symptom onset is associated with greater visual recovery compared with initial tap-and-inject therapy in exogenous infectious endophthalmitis.
METHODS
Retrospective cohort study of consecutive patients with exogenous infectious endop...
Chia-An Hsu, Meng-Jou Chen, Chang-Chi Weng et al.· Ocular immunology and inflam...· 0 citations
Diabetic macular edema (DME) is a common microvascular complication of diabetes and a major cause of vision impairment. Intravitreal vascular endothelial growth factor (VEGF) inhibitors remain the gold standard for its management. However, the high cost and limited accessibility of reference anti-VEGF agents have drive...
Vanaja Jain, V. Dave, Manoj P. Shettigar et al.· Indian Journal of Ophthalmol...· 0 citations
Computational and experimental data demonstrate that BPRCX807 disrupts CXCR4 receptor interactions and suppresses angiogenic factor expression via inhibition of the CXCR4/p-AKT signaling pathway, representing a promising therapeutic approach for wet-AMD.
Shih-Jie Chou, Chia-Hao Wang, Ping-Hsing Tsai et al.· European Journal of Pharmaco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.